On Monday, Werewolf Therapeutics Inc (NASDAQ: HOWL) opened lower -4.35% from the last session, before settling in for the closing price of $2.30. Price fluctuations for HOWL have ranged from $1.66 to $8.19 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 5.40% annually for the last half of the decade. Company’s average yearly earnings per share was noted -46.03% at the time writing. With a float of $32.70 million, this company’s outstanding shares have now reached $39.11 million.
In an organization with 47 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 59.3%, operating margin of -1942.03%, and the pretax margin is -1834.55%.
Werewolf Therapeutics Inc (HOWL) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Werewolf Therapeutics Inc is 26.61%, while institutional ownership is 57.27%.
Werewolf Therapeutics Inc (HOWL) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.33 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.43) by 0.1. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.59 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -46.03% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 10.90% during the next five years compared to -13.31% drop over the previous five years of trading.
Werewolf Therapeutics Inc (NASDAQ: HOWL) Trading Performance Indicators
Check out the current performance indicators for Werewolf Therapeutics Inc (HOWL). In the past quarter, the stock posted a quick ratio of 10.10. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 29.70.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.50, a number that is poised to hit -0.42 in the next quarter and is forecasted to reach -1.85 in one year’s time.
Technical Analysis of Werewolf Therapeutics Inc (HOWL)
Let’s dig in a bit further. During the last 5-days, its volume was 0.7 million. That was better than the volume of 0.37 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 9.70%. Additionally, its Average True Range was 0.27.
During the past 100 days, Werewolf Therapeutics Inc’s (HOWL) raw stochastic average was set at 21.43%, which indicates a significant increase from 3.41% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 74.42% in the past 14 days, which was lower than the 114.76% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.27, while its 200-day Moving Average is $3.95. However, in the short run, Werewolf Therapeutics Inc’s stock first resistance to watch stands at $2.32. Second resistance stands at $2.43. The third major resistance level sits at $2.53. If the price goes on to break the first support level at $2.11, it is likely to go to the next support level at $2.01. Assuming the price breaks the second support level, the third support level stands at $1.90.
Werewolf Therapeutics Inc (NASDAQ: HOWL) Key Stats
There are currently 43,702K shares outstanding in the company with a market cap of 100.67 million. Presently, the company’s annual sales total 19,940 K according to its annual income of -37,370 K. Last quarter, the company’s sales amounted to 1,140 K and its income totaled -17,250 K.
